Rethinking Cell Therapeutics… As An Acquirer? (CTICD)
Cell Therapeutics, Inc. (NASDAQ: CTICD) has long been a controversial stock. It has brought many rewards for investors and it has also brought much pain to investors. We recently featured ...Read Full Story »



